Quest Diagnostics (DGX) Q2 Earnings
Quest Diagnostics Inc DGX posted a better-than-expected Q2 FY22 adjusted EPS of $2.36, though down 25.8% Y/Y, beating the consensus of $2.20. Sales came in at $2.45 billion, a decline…
Quest Diagnostics Inc DGX posted a better-than-expected Q2 FY22 adjusted EPS of $2.36, though down 25.8% Y/Y, beating the consensus of $2.20. Sales came in at $2.45 billion, a decline…
Johnson & Johnson JNJ has reported Q2 FY22 adjusted earnings of $2.59 per share, up 4.4% Y/Y and slightly ahead of the consensus of $2.57. Net sales increased 3% Y/Y…